JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lamarche, Y.
Right arrow Articles by Perrault, L.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamarche, Y.
Right arrow Articles by Perrault, L.P.
Related Collections
Right arrow Extracorporeal circulation

J Thorac Cardiovasc Surg 2005;130:83-92
© 2005 The American Association for Thoracic Surgery


Cardiopulmonary Support and Physiology

Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass

Y. Lamarche, MD a , b , O. Malo, MSc a , E. Thorin, PhD b , A. Denault, MD d , M. Carrier, MD, MSc a , b , J. Roy, CPP e , L.P. Perrault, MD, PhD a , b , c , *

a Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
b Department of Surgery, Montreal Heart Institute, Montreal, Quebec, Canada
c Department of Pharmacology, University of Montreal, Montreal, Quebec, Canada
d Department of Anesthesiology, Montreal Heart Institute, Montreal, Quebec, Canada
e Department of Perfusion, Montreal Heart Institute, Montreal, Quebec, Canada.

Received for publication February 3, 2004; revisions received August 25, 2004; accepted for publication September 2, 2004.

* Address for reprints: Dr Louis P. Perrault, Research Center, Montreal Heart Institute, 5000 Belanger St East, Montreal, Quebec, H1T 1C8, Canada (Email: louis.perrault{at}icm-mhi.org).

OBJECTIVE: Cardiopulmonary bypass triggers a systemic inflammatory response that alters pulmonary endothelial function, which can contribute to pulmonary hypertension. Milrinone is a type III phosphodiesterase inhibitor. The objective of this study was to compare the effects of inhaled and intravenous milrinone on the pulmonary endothelium-dependent relaxations and hemodynamic and oxygenation parameters after cardiopulmonary bypass in a porcine model.

METHODS: Five groups of Landrace swine were compared: (1) control group, no cardiopulmonary bypass; (2) bypass group, 90 minutes of normothermic bypass and 60 minutes of reperfusion; (3) inhaled milrinone group, bypass preceded by a 1.8-mg bolus of inhaled milrinone followed by a continuous milrinone nebulization; (4) intravenous milrinone group, bypass preceded by 2 mg of intravenous milrinone; and (5) inhaled NaCl group, bypass preceded by inhaled saline solution. After sacrifice, pulmonary arterial endothelium-dependent relaxations to acetylcholine and bradykinin were studied in organ chambers.

RESULTS: Inhaled milrinone caused less hypotension (P < .05), a lesser decrease in peripheral vascular resistances (P < .01), and a lower heart rate (P < .05) than intravenous milrinone. Inhaled milrinone prevented the alterations in relaxations of pulmonary arteries to acetylcholine caused by cardiopulmonary bypass, and relaxations to bradykinin were improved in the inhaled milrinone group (P < .05) compared with the cardiopulmonary bypass and control groups.

CONCLUSIONS: Inhaled milrinone prevents the occurrence of the pulmonary endothelial dysfunction seen after cardiopulmonary bypass. The hemodynamic and oxygenation profiles obtained with inhaled milrinone are safer than with intravenous milrinone. These strategies might be useful in preventing pulmonary hypertension after cardiac surgery.





This article has been cited by other articles:


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
K. Subramaniam and J.-P. Yared
Management of Pulmonary Hypertension in the Operating Room
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2007; 11(2): 119 - 136.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Lamarche, L. P. Perrault, S. Maltais, K. Tetreault, J. Lambert, and A. Y. Denault
Preliminary experience with inhaled milrinone in cardiac surgery
Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1081 - 1087.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. Y. Denault, Y. Lamarche, P. Couture, F. Haddad, J. Lambert, J.-C. Tardif, and L. P. Perrault
Inhaled milrinone: a new alternative in cardiac surgery?
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 346 - 360.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The American Association for Thoracic Surgery.